Publication:
Sweet syndrome following vemurafenib therapy for recurrent cholangiocarcinoma

Simple item page
dc.contributor.authorPenvadee Pattanaprichakulen_US
dc.contributor.authorMichael T. Tetzlaffen_US
dc.contributor.authorWhitney J. Lapollaen_US
dc.contributor.authorCarlos A. Torres-Cabalaen_US
dc.contributor.authorMadeleine Duvicen_US
dc.contributor.authorVictor G. Prietoen_US
dc.contributor.authorKenneth Y. Tsaien_US
dc.contributor.authorJonathan L. Curryen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUniversity of Texas MD Anderson Cancer Centeren_US
dc.date.accessioned2018-11-09T02:39:28Z
dc.date.available2018-11-09T02:39:28Z
dc.date.issued2014-03-01en_US
dc.identifier.citationJournal of Cutaneous Pathology. Vol.41, No.3 (2014), 326-328en_US
dc.identifier.doi10.1111/cup.12273en_US
dc.identifier.issn16000560en_US
dc.identifier.issn03036987en_US
dc.identifier.other2-s2.0-84894514269en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/34277
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84894514269&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleSweet syndrome following vemurafenib therapy for recurrent cholangiocarcinomaen_US
dc.typeLetteren_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84894514269&origin=inwarden_US

Files

Collections

Scopus 2011-2015

We collect and process your personal information for the following purposes: Authentication, Preferences, Acknowledgement and Statistics.
To learn more, please read our privacy policy.